LAUSANNE, Switzerland — (BUSINESS WIRE) — Philip Morris International Inc. (PMI) (NYSE: PM) today announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a …
Philip Morris International Acquires Inhaled Drug Specialist OtiTopic; Growing Pipeline of 「Beyond Nicotine」 Inhaled Therapeutic Products
LAUSANNE, Switzerland — (BUSINESS WIRE) — Philip Morris International Inc. (PMI) (NYSE: PM) today announced its acquisition of OtiTopic, a U.S. respiratory drug development company with a …